Literature DB >> 6381559

Bitemporal hypometabolism in Creutzfeldt-Jakob disease measured by positron emission tomography with [18F]-2-fluorodeoxyglucose.

R P Friedland, S B Prusiner, W J Jagust, T F Budinger, R L Davis.   

Abstract

It is well established that Creutzfeldt-Jakob disease (CJD) is caused by a slow infectious agent similar to the scrapie prion. However, the pathogenesis of this infection is poorly understood. Positron emission tomography (PET) was performed on a 54-year-old man with autopsy confirmed CJD using [18F]-2-fluorodeoxyglucose (FDG) and the Donner 280-crystal tomograph. Temporal lobe hypometabolism with hemispheric asymmetry was observed. These findings are similar to those previously obtained in PET-FDG studies of patients with clinically defined Alzheimer disease (AD). The similarities in the regional metabolic alterations between CJD and AD provide additional evidence for the possibility that AD may be caused by a slow infectious prion.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6381559     DOI: 10.1097/00004728-198410000-00034

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  5 in total

1.  Glucose metabolism in sporadic Creutzfeldt-Jakob disease: a statistical parametric mapping analysis of (18) F-FDG PET.

Authors:  E-J Kim; S-S Cho; B-H Jeong; Y-S Kim; S W Seo; D L Na; M D Geschwind; Y Jeong
Journal:  Eur J Neurol       Date:  2011-11-04       Impact factor: 6.089

2.  High neuron-specific enolase level of cerebrospinal fluid in the early stage of Creutzfeldt-Jakob disease.

Authors:  Y Wakayama; S Shibuya; J Kawase; F Sagawa; Y Hashizume
Journal:  Klin Wochenschr       Date:  1987-08-17

3.  Reductions in parietal and temporal cerebral metabolic rates for glucose are not specific for Alzheimer's disease.

Authors:  M B Schapiro; P Pietrini; C L Grady; M J Ball; C DeCarli; A Kumar; J A Kaye; J V Haxby
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-08       Impact factor: 10.154

4.  Glucose metabolism in nine patients with probable sporadic Creutzfeldt-Jakob disease: FDG-PET study using SPM and individual patient analysis.

Authors:  Dimitri Renard; Rik Vandenberghe; Laurent Collombier; Pierre-Olivier Kotzki; Jean-Pierre Pouget; Vincent Boudousq
Journal:  J Neurol       Date:  2013-09-26       Impact factor: 4.849

5.  Brain dopamine transporter binding and glucose metabolism in progressive supranuclear palsy-like creutzfeldt-jakob disease.

Authors:  Eero Rissanen; Valtteri Kaasinen; Pirkko Sonninen; Matias Röyttä; Markku Päivärinta
Journal:  Case Rep Neurol       Date:  2014-01-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.